// App-Quantinova.ai

: Efficacy and Safety of Apixaban for Treatment of Venous Thromboembolism in a Daily Practice‐based Cohort

Researchers

Presenter

  • S.V. Hendriks

Principal Investigators

  • F.A. Klok

  • W.J.E. Stenger

  • A.T.A. Mairuhu

  • J. Eikenboom

  • J. Fogteloo

  • F.J.M. van derMeer

  • M.V. Huisman

Medical Centers

  • Leiden University Medical Center, Dept. of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden, the Netherlands

  • Haga Teaching Hospital, Department of Internal Medicine, The Hague, the Netherlands

  • Leiden University Medical Center, Department of Acute Internal Medicine, Leiden, the Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved